Cambridge Biotherapies Opens New Facility in Beverly, Massachusetts

January 9, 2024

Cybin: Psilocybin Trial Participants Experience Nearly 80% Reduction in Depression Symptoms

January 4, 2024

Beckley Psytech Secures $50 Million Investment from atai to Advance Short-Duration Psychedelic Therapies

January 4, 2024

Silo Pharma Gets Green Light to Start Development of Ketamine Implant for Pain Relief

December 29, 2023

MindBio Therapeutics Reports Progress on LSD Trial for Depression

December 21, 2023

NRx Announces Data-Sharing Agreement with Columbia University for Results from IV Ketamine Trial

December 19, 2023